- The trend backdrop is active with a 3-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
GETI-B
STO
Week ended 07 Aug 2026
Weekly Investor Report
Getinge AB (publ) · Healthcare · Medical Devices
Latest close
237.0 SEK
-0.2%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 18.8% above the Trend Line and sits at 93.2% of its 52-week range. The latest completed week returned -0.2%, after a 14.1% four-week move. The latest news-sentiment score is 57/100. Near-term considerations: price is close to its 52-week high.
Setup score
61
out of 100
Latest Close
237.0 SEK
7 Aug 2026
1W Return
-0.2%
latest completed week
4W Return
14.1%
short-term follow-through
12W Return
25.3%
quarterly tape
Trend Breadth
44.2%
23 of 52 weeks active
Volume Ratio
1.2x
vs 13-week average
- Next-week expectancy is negative at 42.01% based on similar historical setup states.
- 1 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.2%
Latest completed week; four-week move 14.1%.
Indicator stack
35/87
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 42.01%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
57/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 18.8% above the Trend Line and sits at 93.2% of its 52-week range. The latest completed week returned -0.2%, after a 14.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5112-week average 0.25
12-week confirmation
Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.51Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers
No recent accumulation markers. 1 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 14.1% over four weeks, 25.3% over 12 weeks, and 22.8% over one year. The current trend has remained active for 3 consecutive weeks.
Performance by holding period
Active trend streak3 weeks
Active weeks in one year23
Trend breadth44.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.64Latest activity-pressure read.
Pressure change88.9%Four-week change in activity pressure.
Leadership3.65Latest relative-leadership reading.
RS change165.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment57/100
Weighted news tone is neutral across 3 relevant articles.
1 positive · 2 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-2.0%Distance below the 52-week high.
13-week volatility3.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+11.9%Week of 17 Jul.
Worst week-4.4%Week of 1 May.
Latest week-0.2%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains11
Flat weeks0
Modest losses10
Sharp losses2
Recent vol3.7%13-week weekly-return volatility.
Base vol3.4%52-week weekly-return volatility.
Up/down split27/24Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -2.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank10 / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Medical Devices
4-week rank3 / 46
Group average-3.1%
Trend breadth23.9%
Trend23.9%active weekly trend signals
MD41.3%positive activity pressure
RS10.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape54/100
Trend, activity pressure, participation, and risk combine to a 54/100 tape read.
Indicator analysis49/100Latest 12-week confirmation: trend 3/12, activity pressure 12/12, relative leadership 4/12.
Activity pressure 0.51; 1 reversal markers Next-Week ExpectancyNegative 42.01%Next-week expectancy is negative with a 42.01% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment57/100Weighted news tone is neutral across 3 relevant articles.
Getinge AB (publ) Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 237.0 SEK | -0.2% | 199.5 SEK | 194.9 SEK | 1.64 | 3.65 | 2.6M | On |
| 31 Jul 2026 | 237.4 SEK | 3.1% | 198.9 SEK | 194.5 SEK | 1.57 | 5.84 | 2.2M | On |
| 24 Jul 2026 | 230.3 SEK | -0.9% | 198.1 SEK | 194.1 SEK | 1.43 | 4.19 | 2.5M | On |
| 17 Jul 2026 | 232.5 SEK | 11.9% | 197.3 SEK | 193.8 SEK | 1.18 | 6.84 | 5.8M | Off |
| 10 Jul 2026 | 207.7 SEK | -0.1% | 196.5 SEK | 193.5 SEK | 0.87 | -5.56 | 2.9M | Off |
| 3 Jul 2026 | 208.0 SEK | 5.3% | 196.4 SEK | 193.3 SEK | 0.62 | -7.61 | 633.7K | Off |
| 26 Jun 2026 | 197.6 SEK | 1.9% | 196.4 SEK | 193.0 SEK | 0.41 | -9.92 | 407.8K | Off |
| 19 Jun 2026 | 193.9 SEK | -1.2% | 196.8 SEK | 192.9 SEK | 0.31 | -12.54 | 1.9M | Off |
| 12 Jun 2026 | 196.2 SEK | 1.0% | 197.1 SEK | 192.7 SEK | 0.34 | -9.92 | 671.6K | Off |
| 5 Jun 2026 | 194.4 SEK | 2.4% | 197.5 SEK | 193.0 SEK | 0.18 | -11.12 | 295.8K | Off |
| 29 May 2026 | 189.9 SEK | -3.3% | 198.1 SEK | 193.2 SEK | 0.20 | -14.04 | 2.7M | Off |
| 22 May 2026 | 196.2 SEK | 3.8% | 199.1 SEK | 193.5 SEK | 0.01 | -11.66 | 3.3M | Off |
| 15 May 2026 | 189.1 SEK | 0.2% | 199.8 SEK | 193.8 SEK | -0.21 | -12.03 | 2.3M | Off |
| 8 May 2026 | 188.7 SEK | 2.8% | 200.4 SEK | 194.1 SEK | -0.23 | -13.57 | 3.7M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.